SINO BIOPHARMACEUT
- Market cap
- 14.50B
- P/E (TTM)i
- 38.99
- P/Bi
- 2.72
- EPSi
- 0.38
- Div yieldi
- 2.07%
- 52W posi
- 40%
Anonymous reader poll. Unscientific, not investment advice.
SINO BIOPHARMACEUT last traded at 14.82, up 2.46% on the session. At current prices, the business is worth about 14.50B, the #1154 most valuable US-listed company we track. The stock also carries a trailing dividend yield of 2.07%. The shares sit 40% of the way up their 52-week range of 11.27 to 20.16.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 1 week.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 14.46
- Open
- 14.50
- Day range
- 14.50 - 14.50
- Avg price
- --
- Volume
- 202
- Turnover
- 2.99K
- Turnover ratei
- 0.00%
- Amplitudei
- 0.00%
- 52-week rangei
- 11.27 - 20.16
Valuation
- P/Ei
- --
- P/E (TTM)i
- 38.99
- P/Bi
- 2.72
- EPSi
- 0.38
- Book value / shi
- 5.44
- Net profit
- --
- Net assets
- --
Share structure
- Market cap
- 14.50B
- Float capi
- --
- Shares out
- 978.56M
- Float sharesi
- 978.56M
Dividend & listing
- Div yield (TTM)i
- 2.07%
- Dividend (TTM)
- 0.30
- Listing date
- 1970-01-01
26.5% below the 52-week high
Frequently asked questions
What is the current stock price of SINO BIOPHARMACEUT (SBHMY)?
SINO BIOPHARMACEUT last traded at 14.82. The quote on this page refreshes every few seconds while US markets are open.
What is SINO BIOPHARMACEUT's market cap?
About 14.50B.
What is the P/E ratio of SINO BIOPHARMACEUT?
The trailing twelve-month P/E is 38.99. The Valuation tab shows it against the stock's own five-year range.
Does SINO BIOPHARMACEUT pay a dividend?
Yes. The trailing dividend yield is 2.07%. See the Dividends tab for the full payment history.
What is SINO BIOPHARMACEUT's StockVane Quant Rating?
The StockVane Momentum strategy currently rates SINO BIOPHARMACEUT a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 18:50:38 · For reference only, not investment advice and not tailored to your situation.